Skip to main content
Erschienen in:

25.09.2018 | Original Article

MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity

verfasst von: Matteo Marti, Margherita Neri, Sabrine Bilel, Marco Di Paolo, Raffaele La Russa, Andrea Ossato, Emanuela Turillazzi

Erschienen in: Forensic Toxicology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

MDMA is a psychoactive drug that has been increasingly abused worldwide, due to its entactogenic properties. However, concerns on its safety exist, particularly regarding its effects on attentional skills and performance. Evidence from the literature shows contrasting effects of MDMA. It generally acts as a pshychomotor stimulant, thus improving arousal and psychomotor function. However, MDMA has been demonstrated to negatively influence other skills. Consequently, human activities that require alertness, and accurate and quick reflexes (i.e. driving, operations at the workplace, etc.) could be negatively affected. In the present study, the effect of MDMA (0.1–20 mg/kg, intraperitoneally) on sensorimotor and startle/prepulse inhibition responses was evaluated in a controlled rodent experimental setting.

Methods

Sensorimotor studies, evaluation of visual, acoustic, and tactile responses, evaluation of spontaneous locomotion, startle and repulse inhibition analyses were performed in an experimental controlled rodent model (rats and mice), following the administration of MDMA (0.1–20 mg/kg) intraperitoneally.

Results

Our findings show that all the MDMA-treated animals had impaired sensorimotor and prepulse inhibition responses compared to the control subjects at the early (5, 30 and 60 min) testing time points while all the effects disappeared, respectively, 6, 16 and 24 h post-MDMA treatment.

Conclusions

Within the ongoing debate on the safety of recreational abuse of MDMA, our results reveal acute prominent changes in sensorimotor and attentional performance, sensor response to external stimuli, and locomotor activity due to a single administration of a dose of MDMA (corresponding to a dose producing in humans both ‘desirable’ entactogenic effects and physiological adverse effects).
Literatur
2.
Zurück zum Zitat Dumont GJ, Verkes RJ (2006) A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers. J Psychopharmacol 20:176–187CrossRefPubMed Dumont GJ, Verkes RJ (2006) A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers. J Psychopharmacol 20:176–187CrossRefPubMed
3.
Zurück zum Zitat Sumnall HR, Cole JC, Jerome L (2006) The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy. J Psychopharmacol 20:670–682CrossRefPubMed Sumnall HR, Cole JC, Jerome L (2006) The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy. J Psychopharmacol 20:670–682CrossRefPubMed
4.
Zurück zum Zitat Carvalho M, Carmo H, Costa VM, Capela JP, Pontes H, Remiao F, Carvalho F, Bastos Mde L (2012) Toxicity of amphetamines: an update. Archives Toxicol 86:1167–1231CrossRef Carvalho M, Carmo H, Costa VM, Capela JP, Pontes H, Remiao F, Carvalho F, Bastos Mde L (2012) Toxicity of amphetamines: an update. Archives Toxicol 86:1167–1231CrossRef
5.
Zurück zum Zitat Moratalla R, Khairnar A, Simola N, Granado N, Garcia-Montes JR, Porceddu PF, Tizabi Y, Costa G, Morelli M (2017) Amphetamine-related drugs neurotoxicity in humans and in experimental animals: main mechanisms. Prog Neurobiol 155:149–170CrossRefPubMed Moratalla R, Khairnar A, Simola N, Granado N, Garcia-Montes JR, Porceddu PF, Tizabi Y, Costa G, Morelli M (2017) Amphetamine-related drugs neurotoxicity in humans and in experimental animals: main mechanisms. Prog Neurobiol 155:149–170CrossRefPubMed
6.
Zurück zum Zitat Riezzo I, Cerretani D, Fiore C, Bello S, Centini F, D’Errico S, Fiaschi AI, Giorgi G, Neri M, Pomara C, Turillazzi E, Fineschi V (2010) Enzymatic-nonenzymatic cellular antioxidant defense systems response and immunohistochemical detection of MDMA, VMAT2, HSP70, and apoptosis as biomarkers for MDMA (Ecstasy) neurotoxicity. J Neurosci Res 88:905–916 Riezzo I, Cerretani D, Fiore C, Bello S, Centini F, D’Errico S, Fiaschi AI, Giorgi G, Neri M, Pomara C, Turillazzi E, Fineschi V (2010) Enzymatic-nonenzymatic cellular antioxidant defense systems response and immunohistochemical detection of MDMA, VMAT2, HSP70, and apoptosis as biomarkers for MDMA (Ecstasy) neurotoxicity. J Neurosci Res 88:905–916
8.
Zurück zum Zitat Parrott AC (2013) Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research. H Psychopharmacol 28:289–307CrossRef Parrott AC (2013) Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research. H Psychopharmacol 28:289–307CrossRef
9.
Zurück zum Zitat Lamers CT, Ramaekers JG, Muntjewerff ND, Sikkema KL, Samyn N, Read NL, Brookhuis KA, Riedel WJ (2003) Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance. J Psychopharmacol 17:379–387CrossRefPubMed Lamers CT, Ramaekers JG, Muntjewerff ND, Sikkema KL, Samyn N, Read NL, Brookhuis KA, Riedel WJ (2003) Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance. J Psychopharmacol 17:379–387CrossRefPubMed
10.
Zurück zum Zitat Dumont GJ, Wezenberg E, Valkenberg MM, de Jong CA, Buitelaar JK, van Gerven JM, Verkes RJ (2008) Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers. Psychopharmacology 197:465–474CrossRefPubMedPubMedCentral Dumont GJ, Wezenberg E, Valkenberg MM, de Jong CA, Buitelaar JK, van Gerven JM, Verkes RJ (2008) Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers. Psychopharmacology 197:465–474CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Ramaekers JG, Kuypers KP (2006) Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol. Neuropsychopharmacology 31:1048–1055CrossRefPubMed Ramaekers JG, Kuypers KP (2006) Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol. Neuropsychopharmacology 31:1048–1055CrossRefPubMed
12.
Zurück zum Zitat Kuypers KP, Ramaekers JG (2005) Transient memory impairment after acute dose of 75 mg 3.4-methylene-dioxymethamphetamine. J Psychopharmacol 19:633–639CrossRefPubMed Kuypers KP, Ramaekers JG (2005) Transient memory impairment after acute dose of 75 mg 3.4-methylene-dioxymethamphetamine. J Psychopharmacol 19:633–639CrossRefPubMed
13.
Zurück zum Zitat Bosker WM, Kuypers KP, Conen S, Kauert GF, Toennes SW, Skopp G, Ramaekers JG (2012) MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid. Psychopharmacology 222:367–376CrossRefPubMed Bosker WM, Kuypers KP, Conen S, Kauert GF, Toennes SW, Skopp G, Ramaekers JG (2012) MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid. Psychopharmacology 222:367–376CrossRefPubMed
14.
Zurück zum Zitat Martin JK, Kraft JM, Roman PM (1994) extent and impact of alcohol and drug use problems in the workplace. In: Macdonald S, Roman P (eds) Drug testing in the workplace. Springer, Boston, pp 3–31CrossRef Martin JK, Kraft JM, Roman PM (1994) extent and impact of alcohol and drug use problems in the workplace. In: Macdonald S, Roman P (eds) Drug testing in the workplace. Springer, Boston, pp 3–31CrossRef
15.
Zurück zum Zitat Kuypers KP, Wingen M, Samyn N, Limbert N, Ramaekers JG (2007) Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night. Psychopharmacology 192:111–119CrossRefPubMed Kuypers KP, Wingen M, Samyn N, Limbert N, Ramaekers JG (2007) Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night. Psychopharmacology 192:111–119CrossRefPubMed
16.
Zurück zum Zitat Bosanquet D, Macdougall HG, Rogers SJ, Starmer GA, McKetin R, Blaszczynski A, McGregor IS (2013) Driving on ice: impaired driving skills in current methamphetamine users. Psychopharmacology 225:161–172CrossRefPubMed Bosanquet D, Macdougall HG, Rogers SJ, Starmer GA, McKetin R, Blaszczynski A, McGregor IS (2013) Driving on ice: impaired driving skills in current methamphetamine users. Psychopharmacology 225:161–172CrossRefPubMed
17.
Zurück zum Zitat Matthews AJ, Bruno R, Dietze P, Butler K, Burns L (2014) Driving under the influence among frequent ecstasy consumers in Australia: trends over time and the role of risk perceptions. Drug Alcohol Depend 144:218–224CrossRefPubMed Matthews AJ, Bruno R, Dietze P, Butler K, Burns L (2014) Driving under the influence among frequent ecstasy consumers in Australia: trends over time and the role of risk perceptions. Drug Alcohol Depend 144:218–224CrossRefPubMed
18.
Zurück zum Zitat Edvardsen HM, Moan IS, Christophersen AS, Gjerde H (2015) Use of alcohol and drugs by employees in selected business areas in Norway: a study using oral fluid testing and questionnaires. J Occup Med Toxicol 10:46CrossRefPubMedPubMedCentral Edvardsen HM, Moan IS, Christophersen AS, Gjerde H (2015) Use of alcohol and drugs by employees in selected business areas in Norway: a study using oral fluid testing and questionnaires. J Occup Med Toxicol 10:46CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Mohamed WM, Ben Hamida S, Cassel JC, de Vasconcelos AP, Jones BC (2011) MDMA: interactions with other psychoactive drugs. Pharmacol Biochem Behav 99:759–774CrossRefPubMed Mohamed WM, Ben Hamida S, Cassel JC, de Vasconcelos AP, Jones BC (2011) MDMA: interactions with other psychoactive drugs. Pharmacol Biochem Behav 99:759–774CrossRefPubMed
20.
Zurück zum Zitat Morefield KM, Keane M, Felgate P, White JM, Irvine RJ (2011) Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational ‘ecstasy’ users. Addiction 106:1293–1300CrossRefPubMed Morefield KM, Keane M, Felgate P, White JM, Irvine RJ (2011) Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational ‘ecstasy’ users. Addiction 106:1293–1300CrossRefPubMed
21.
Zurück zum Zitat Cerretani D, Bello S, Cantatore S, Fiaschi AI, Montefrancesco G, Neri M, Pomara C, Riezzo I, Fiore C, Bonsignore A, Turillazzi E, Fineschi V (2011) Acute administration of 3,4-methylenedioxymethamphetamine (MDMA) induces oxidative stress, lipoperoxidation and TNFalpha-mediated apoptosis in rat liver. Pharmacol Res 64:517–527CrossRefPubMed Cerretani D, Bello S, Cantatore S, Fiaschi AI, Montefrancesco G, Neri M, Pomara C, Riezzo I, Fiore C, Bonsignore A, Turillazzi E, Fineschi V (2011) Acute administration of 3,4-methylenedioxymethamphetamine (MDMA) induces oxidative stress, lipoperoxidation and TNFalpha-mediated apoptosis in rat liver. Pharmacol Res 64:517–527CrossRefPubMed
22.
Zurück zum Zitat Neri M, Bello S, Bonsignore A, Centini F, Fiore C, Foldes-Papp Z, Turillazzi E, Fineschi V (2010) Myocardial expression of TNF-alpha, IL-1beta, IL-6, IL-8, IL-10 and MCP-1 after a single MDMA dose administered in a rat model. Curr Pharmaceut Biotechnol 11:413–420CrossRef Neri M, Bello S, Bonsignore A, Centini F, Fiore C, Foldes-Papp Z, Turillazzi E, Fineschi V (2010) Myocardial expression of TNF-alpha, IL-1beta, IL-6, IL-8, IL-10 and MCP-1 after a single MDMA dose administered in a rat model. Curr Pharmaceut Biotechnol 11:413–420CrossRef
23.
Zurück zum Zitat Cami G, Server-Carrio J, Fustero S, Pedregosa J (2000) A novel heterocyclic sulfonamide: N-benzyl-5-[N-benzyl-N-(tert-butyloxycarbonyl)amino]-N-(tert-butyloxycarbonyl)-1, 3,4-thiadiazole-2-sulfonamide. Acta Crystallographica. Section C, Crystal Struct Commun 56:E209–E210CrossRef Cami G, Server-Carrio J, Fustero S, Pedregosa J (2000) A novel heterocyclic sulfonamide: N-benzyl-5-[N-benzyl-N-(tert-butyloxycarbonyl)amino]-N-(tert-butyloxycarbonyl)-1, 3,4-thiadiazole-2-sulfonamide. Acta Crystallographica. Section C, Crystal Struct Commun 56:E209–E210CrossRef
24.
Zurück zum Zitat Hamdam J, Sethu S, Smith T, Alfirevic A, Alhaidari M, Atkinson J, Ayala M, Box H, Cross M, Delaunois A, Dermody A, Govindappa K, Guillon J-M, Jenkins R, Kenna G, Lemmer B, Meecham K, Olayanju A, Pestel S, Rothfuss A, Sidaway J, Sison-Young R, Smith E, Stebbings R, Tingle Y, Valentin J-P, Williams A, Williams D, Park K, Goldring C (2013) Safety pharmacology—current and emerging concepts. Toxicol Appl Pharmacol 273:229–241CrossRefPubMed Hamdam J, Sethu S, Smith T, Alfirevic A, Alhaidari M, Atkinson J, Ayala M, Box H, Cross M, Delaunois A, Dermody A, Govindappa K, Guillon J-M, Jenkins R, Kenna G, Lemmer B, Meecham K, Olayanju A, Pestel S, Rothfuss A, Sidaway J, Sison-Young R, Smith E, Stebbings R, Tingle Y, Valentin J-P, Williams A, Williams D, Park K, Goldring C (2013) Safety pharmacology—current and emerging concepts. Toxicol Appl Pharmacol 273:229–241CrossRefPubMed
25.
Zurück zum Zitat Canazza I, Ossato A, Trapella C, Fantinati A, De Luca MA, Margiani G, Vincenzi F, Rimondo C, Di Rosa F, Gregori A, Varani K, Borea PA, Serpelloni G, Marti M (2016) Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies. Psychopharmacology 233:3685–3709CrossRefPubMed Canazza I, Ossato A, Trapella C, Fantinati A, De Luca MA, Margiani G, Vincenzi F, Rimondo C, Di Rosa F, Gregori A, Varani K, Borea PA, Serpelloni G, Marti M (2016) Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies. Psychopharmacology 233:3685–3709CrossRefPubMed
26.
Zurück zum Zitat Ossato A, Canazza I, Trapella C, Vincenzi F, De Luca MA, Rimondo C, Varani K, Borea PA, Serpelloni G, Marti M (2016) Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. Prog Neuro-Psychopharmacol Biol Psychiat 67:31–50CrossRef Ossato A, Canazza I, Trapella C, Vincenzi F, De Luca MA, Rimondo C, Varani K, Borea PA, Serpelloni G, Marti M (2016) Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. Prog Neuro-Psychopharmacol Biol Psychiat 67:31–50CrossRef
27.
Zurück zum Zitat Ossato A, Vigolo A, Trapella C, Seri C, Rimondo C, Serpelloni G, Marti M (2015) JWH-018 impairs sensorimotor functions in mice. Neuroscience 300:174–188CrossRefPubMed Ossato A, Vigolo A, Trapella C, Seri C, Rimondo C, Serpelloni G, Marti M (2015) JWH-018 impairs sensorimotor functions in mice. Neuroscience 300:174–188CrossRefPubMed
28.
Zurück zum Zitat Koch S, Galloway MP (1997) MDMA induced dopamine release in vivo: role of endogenous serotonin. J Neural Transm 104:135–146CrossRefPubMed Koch S, Galloway MP (1997) MDMA induced dopamine release in vivo: role of endogenous serotonin. J Neural Transm 104:135–146CrossRefPubMed
29.
Zurück zum Zitat Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH (2003) Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine (“ecstasy”) and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology 166:202–211CrossRefPubMed Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH (2003) Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine (“ecstasy”) and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology 166:202–211CrossRefPubMed
30.
Zurück zum Zitat Mansbach RS, Braff DL, Geyer MA (1989) Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamine (MDEA) in the rat. Eur J Pharmacol 167:49–55CrossRefPubMed Mansbach RS, Braff DL, Geyer MA (1989) Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamine (MDEA) in the rat. Eur J Pharmacol 167:49–55CrossRefPubMed
31.
Zurück zum Zitat van den Buuse M, Becker T, Kwek P, Martin S, Ruimschotel E, Risbrough V (2011) Disruption of prepulse inhibition by 3,4-methylenedioxymethamphetamine (MDMA): comparison between male and female wild-type and 5-HT(1A) receptor knockout mice. Int J Neuropsychopharmacol 14:856–861CrossRefPubMed van den Buuse M, Becker T, Kwek P, Martin S, Ruimschotel E, Risbrough V (2011) Disruption of prepulse inhibition by 3,4-methylenedioxymethamphetamine (MDMA): comparison between male and female wild-type and 5-HT(1A) receptor knockout mice. Int J Neuropsychopharmacol 14:856–861CrossRefPubMed
32.
Zurück zum Zitat Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, Huestis MA (2009) Effects of dose and route of administration on pharmacokinetics of (+ or −)-3,4-methylenedioxymethamphetamine in the rat. Drug Metab Dispos 37:2163–2170CrossRefPubMedPubMedCentral Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, Huestis MA (2009) Effects of dose and route of administration on pharmacokinetics of (+ or −)-3,4-methylenedioxymethamphetamine in the rat. Drug Metab Dispos 37:2163–2170CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Shiue CY, Shiue GG, Rysavy JA, Pleus RC, Huang H, Bai LQ, Cornish KG, Sunderland JJ, Frick MP (1993) Fluorine-18 and carbon-11 labeled amphetamine analogs—synthesis, distribution, binding characteristics in mice and rats and a PET study in monkey. Nucl Med Biol 20:973–981CrossRefPubMed Shiue CY, Shiue GG, Rysavy JA, Pleus RC, Huang H, Bai LQ, Cornish KG, Sunderland JJ, Frick MP (1993) Fluorine-18 and carbon-11 labeled amphetamine analogs—synthesis, distribution, binding characteristics in mice and rats and a PET study in monkey. Nucl Med Biol 20:973–981CrossRefPubMed
34.
Zurück zum Zitat Esteban B, O’Shea E, Camarero J, Sanchez V, Green AR, Colado MI (2001) 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology 154:251–260CrossRefPubMed Esteban B, O’Shea E, Camarero J, Sanchez V, Green AR, Colado MI (2001) 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology 154:251–260CrossRefPubMed
35.
Zurück zum Zitat Gorska AM, Golembiowska K (2015) The role of adenosine A1 and A2A receptors in the caffeine effect on MDMA-induced DA and 5-HT release in the mouse striatum. Neurotox Res 27:229–245CrossRefPubMed Gorska AM, Golembiowska K (2015) The role of adenosine A1 and A2A receptors in the caffeine effect on MDMA-induced DA and 5-HT release in the mouse striatum. Neurotox Res 27:229–245CrossRefPubMed
36.
Zurück zum Zitat Yamamoto BK, Nash JF, Gudelsky GA (1995) Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. J Pharmacol Exp Ther 273:1063–1070PubMed Yamamoto BK, Nash JF, Gudelsky GA (1995) Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. J Pharmacol Exp Ther 273:1063–1070PubMed
37.
Zurück zum Zitat De Letter EA, Espeel MF, Craeymeersch ME, Lambert WE, Clauwaert KM, Dams R, Mortier KA, Piette MH (2003) Immunohistochemical demonstration of the amphetamine derivatives 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in human post-mortem brain tissues and the pituitary gland. Int J Legal Med 117:2–9PubMed De Letter EA, Espeel MF, Craeymeersch ME, Lambert WE, Clauwaert KM, Dams R, Mortier KA, Piette MH (2003) Immunohistochemical demonstration of the amphetamine derivatives 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in human post-mortem brain tissues and the pituitary gland. Int J Legal Med 117:2–9PubMed
38.
Zurück zum Zitat Canal CE, Morgan D (2012) Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model. Drug Test Anal 4:556–576CrossRefPubMedPubMedCentral Canal CE, Morgan D (2012) Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model. Drug Test Anal 4:556–576CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Gonzalez-Maeso J, Sealfon SC (2009) Agonist-trafficking and hallucinogens. Curr Med Chem 16:1017–1027CrossRefPubMed Gonzalez-Maeso J, Sealfon SC (2009) Agonist-trafficking and hallucinogens. Curr Med Chem 16:1017–1027CrossRefPubMed
40.
Zurück zum Zitat Gonzalez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53:439–452CrossRefPubMed Gonzalez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53:439–452CrossRefPubMed
41.
Zurück zum Zitat Kehne JH, McCloskey TC, Taylor VL, Black CK, Fadayel GM, Schmidt CJ (1992) Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats. J Pharmacol Exp Ther 260:78–89PubMed Kehne JH, McCloskey TC, Taylor VL, Black CK, Fadayel GM, Schmidt CJ (1992) Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats. J Pharmacol Exp Ther 260:78–89PubMed
42.
Zurück zum Zitat Swerdlow NR, Geyer MA, Shoemaker JM, Light GA, Braff DL, Stevens KE, Sharp R, Breier M, Neary A, Auerbach PP (2006) Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology 31:506–515CrossRefPubMedPubMedCentral Swerdlow NR, Geyer MA, Shoemaker JM, Light GA, Braff DL, Stevens KE, Sharp R, Breier M, Neary A, Auerbach PP (2006) Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology 31:506–515CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Papesh MA, Hurley LM (2016) Modulation of auditory brainstem responses by serotonin and specific serotonin receptors. Hearing Res 332:121–136CrossRef Papesh MA, Hurley LM (2016) Modulation of auditory brainstem responses by serotonin and specific serotonin receptors. Hearing Res 332:121–136CrossRef
44.
Zurück zum Zitat Felix RA 2nd, Elde CJ, Nevue AA, Portfors CV (2017) Serotonin modulates response properties of neurons in the dorsal cochlear nucleus of the mouse. Hearing Res 344:13–23CrossRef Felix RA 2nd, Elde CJ, Nevue AA, Portfors CV (2017) Serotonin modulates response properties of neurons in the dorsal cochlear nucleus of the mouse. Hearing Res 344:13–23CrossRef
45.
Zurück zum Zitat Geyer MA, Tapson GS (1988) Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors. Neuropsychopharmacology 1:135–147CrossRefPubMed Geyer MA, Tapson GS (1988) Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors. Neuropsychopharmacology 1:135–147CrossRefPubMed
46.
Zurück zum Zitat Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117–154CrossRefPubMed Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117–154CrossRefPubMed
47.
Zurück zum Zitat Dulawa SC, Geyer MA (2000) Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology 39:2170–2179CrossRefPubMed Dulawa SC, Geyer MA (2000) Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology 39:2170–2179CrossRefPubMed
48.
Zurück zum Zitat Graham FK (1975) Presidential Address. 1974. The more or less startling effects of weak prestimulation. Psychophysiology 12:238–248CrossRefPubMed Graham FK (1975) Presidential Address. 1974. The more or less startling effects of weak prestimulation. Psychophysiology 12:238–248CrossRefPubMed
49.
Zurück zum Zitat Siegel SJ, Talpos JC, Geyer MA (2013) Animal models and measures of perceptual processing in schizophrenia. Neurosci Biobehav Rev 37:2092–2098CrossRefPubMed Siegel SJ, Talpos JC, Geyer MA (2013) Animal models and measures of perceptual processing in schizophrenia. Neurosci Biobehav Rev 37:2092–2098CrossRefPubMed
50.
Zurück zum Zitat White SR, Duffy P, Kalivas PW (1994) Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo. Neuroscience 62:41–50CrossRefPubMed White SR, Duffy P, Kalivas PW (1994) Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo. Neuroscience 62:41–50CrossRefPubMed
51.
Zurück zum Zitat Sprague JE, Everman SL, Nichols DE (1998) An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. Neurotoxicology 19:427–441PubMed Sprague JE, Everman SL, Nichols DE (1998) An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. Neurotoxicology 19:427–441PubMed
52.
Zurück zum Zitat Scearce-Levie K, Viswanathan SS, Hen R (1999) Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor. Psychopharmacology 141:154–161CrossRefPubMed Scearce-Levie K, Viswanathan SS, Hen R (1999) Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor. Psychopharmacology 141:154–161CrossRefPubMed
53.
Zurück zum Zitat Kehne JH, Ketteler HJ, McCloskey TC, Sullivan CK, Dudley MW, Schmidt CJ (1996) Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacology 15:116–124CrossRefPubMed Kehne JH, Ketteler HJ, McCloskey TC, Sullivan CK, Dudley MW, Schmidt CJ (1996) Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacology 15:116–124CrossRefPubMed
54.
Zurück zum Zitat McCreary AC, Bankson MG, Cunningham KA (1999) Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors. J Pharmacol Exp Ther 290:965–973PubMed McCreary AC, Bankson MG, Cunningham KA (1999) Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors. J Pharmacol Exp Ther 290:965–973PubMed
55.
Zurück zum Zitat Lebsanft HB, Mayerhofer A, Kovar KA, Schmidt WJ (2003) Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent? J Neural Transm 110:707–718PubMed Lebsanft HB, Mayerhofer A, Kovar KA, Schmidt WJ (2003) Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent? J Neural Transm 110:707–718PubMed
56.
Zurück zum Zitat Lebsanft HB, Kohles T, Kovar KA, Schmidt WJ (2005) 3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy. Synapse 55:148–155CrossRefPubMed Lebsanft HB, Kohles T, Kovar KA, Schmidt WJ (2005) 3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy. Synapse 55:148–155CrossRefPubMed
57.
Zurück zum Zitat Han DD, Gu HH (2006) Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6:6CrossRefPubMedPubMedCentral Han DD, Gu HH (2006) Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6:6CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Faure P, Tolu S, Valverde S, Naude J (2014) Role of nicotinic acetylcholine receptors in regulating dopamine neuron activity. Neuroscience 282:86–100CrossRefPubMed Faure P, Tolu S, Valverde S, Naude J (2014) Role of nicotinic acetylcholine receptors in regulating dopamine neuron activity. Neuroscience 282:86–100CrossRefPubMed
59.
Zurück zum Zitat Back-Madruga C, Boone KB, Chang L, Grob CS, Lee A, Nations H, Poland RE (2003) Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. Clin Neuropsychol 17:446–459CrossRefPubMed Back-Madruga C, Boone KB, Chang L, Grob CS, Lee A, Nations H, Poland RE (2003) Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. Clin Neuropsychol 17:446–459CrossRefPubMed
60.
Zurück zum Zitat Murphy PN, Bruno R, Ryland I, Wareing M, Fisk JE, Montgomery C, Hilton J (2012) The effects of ‘ecstasy’ (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses. Human Psychopharmacol 27:113–138CrossRef Murphy PN, Bruno R, Ryland I, Wareing M, Fisk JE, Montgomery C, Hilton J (2012) The effects of ‘ecstasy’ (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses. Human Psychopharmacol 27:113–138CrossRef
61.
Zurück zum Zitat Santacroce R, Ruiz Bennasar C, Sancho Jaraiz JR, Fiori F, Sarchione F, Angelini F, Catalano G, Carenti ML, Corkery JM, Schifano F, Di Giannantonio M, Martinotti G (2017) A matter of life and death: substance-caused and substance-related fatalities in Ibiza in 2015. Human Psychopharmacol 32(3):e2592CrossRef Santacroce R, Ruiz Bennasar C, Sancho Jaraiz JR, Fiori F, Sarchione F, Angelini F, Catalano G, Carenti ML, Corkery JM, Schifano F, Di Giannantonio M, Martinotti G (2017) A matter of life and death: substance-caused and substance-related fatalities in Ibiza in 2015. Human Psychopharmacol 32(3):e2592CrossRef
62.
Zurück zum Zitat Ramaekers JG, Kuypers KP, Bosker WM, Brookhuis KA, Veldstra JA, Simons R, Martens M, Hjälmdahl M, Forsman A, Knoche A (2012) Effects of stimulant drugs on actual and simulated driving: perspectives from four experimental studies conducted as part of the DRUID research consortium. Psychopharmacology 222:413–418CrossRefPubMedPubMedCentral Ramaekers JG, Kuypers KP, Bosker WM, Brookhuis KA, Veldstra JA, Simons R, Martens M, Hjälmdahl M, Forsman A, Knoche A (2012) Effects of stimulant drugs on actual and simulated driving: perspectives from four experimental studies conducted as part of the DRUID research consortium. Psychopharmacology 222:413–418CrossRefPubMedPubMedCentral
63.
Zurück zum Zitat Brookhuis KA, de Waard D, Samyn N (2004) Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety. Psychopharmacology 173:440–445CrossRefPubMed Brookhuis KA, de Waard D, Samyn N (2004) Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety. Psychopharmacology 173:440–445CrossRefPubMed
64.
Zurück zum Zitat Silber BY, Croft RJ, Downey LA, Papafotiou K, Camfield DA, Stough C (2012) The effect of d-methamphetamine on simulated driving performance. Human Psychopharmacol 27:139–144CrossRef Silber BY, Croft RJ, Downey LA, Papafotiou K, Camfield DA, Stough C (2012) The effect of d-methamphetamine on simulated driving performance. Human Psychopharmacol 27:139–144CrossRef
65.
Zurück zum Zitat Hayley AC, Downey LA, Shiferaw B, Stough C (2016) Amphetamine-type stimulant use and the risk of injury or death as a result of a road-traffic accident: a systematic review of observational studies. Europ Neuropsychopharmacol 26:901–922CrossRef Hayley AC, Downey LA, Shiferaw B, Stough C (2016) Amphetamine-type stimulant use and the risk of injury or death as a result of a road-traffic accident: a systematic review of observational studies. Europ Neuropsychopharmacol 26:901–922CrossRef
66.
Zurück zum Zitat Bosanquet D, Macdougall HG, Rogers SJ, Starmer GA, McKetin R, Blaszczynski A, McGregor IS (2013) Driving on ice: impaired driving skills in current methamphetamine users. Psychopharmacology 225:161–172CrossRefPubMed Bosanquet D, Macdougall HG, Rogers SJ, Starmer GA, McKetin R, Blaszczynski A, McGregor IS (2013) Driving on ice: impaired driving skills in current methamphetamine users. Psychopharmacology 225:161–172CrossRefPubMed
Metadaten
Titel
MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity
verfasst von
Matteo Marti
Margherita Neri
Sabrine Bilel
Marco Di Paolo
Raffaele La Russa
Andrea Ossato
Emanuela Turillazzi
Publikationsdatum
25.09.2018
Verlag
Springer Japan
Erschienen in
Forensic Toxicology / Ausgabe 1/2019
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-018-0444-7

Neu im Fachgebiet Rechtsmedizin

Pathologie der Milz

Nach einer Beschreibung der Milzanatomie und Darstellung der diagnostisch wichtigsten immunhistochemischen Färbungen zur Identifizierung der normalen Milzkompartimente werden am Beispiel eines nordafrikanischen Patienten mit rezentem …

Molekular definierte Nierenzellkarzinome 2025

Im Zuge der Überarbeitung der WHO-Klassifikation im Jahr 2022 konnten für mehrere Nierenzellkarzinome (NZK), die sich zuvor nicht eindeutig den bis dahin definierten Tumortypen zuordnen ließen, jedoch gemeinsame morphologische und molekulare …

Wichtige Änderungen in der WHO-Klassifikation der Hodentumoren 2022

In der 5. Auflage der „WHO-Klassifikation der Tumoren der ableitenden Harnwege und des männlichen Genitaltrakts“ sind bedeutende Anpassungen an den bisherigen Klassifikationen vorgenommen worden. Diese betreffen bei den Keimzelltumoren des Hodens …

DNA mixture deconvolution using fully continuous models EuroForMix and EFMrep

  • Open Access
  • Originalien

Mixture deconvolution is a powerful tool for inferring individual DNA profiles from DNA mixtures for subsequent transmission to a database or database queries. To carry out deconvolution, a mixed trace can be interpreted either manually by an …